New Drug For Asbestos-Related Cancer Boosts Survival Rates, UK Study Finds
February 16, 2024 19:42A new drug that starves cancer cells of their energy source has shown promising results in a clinical trial for patients with mesothelioma, a rare and incurable cancer caused by exposure to asbestos. The drug, called ADI-PEG20, was combined with chemotherapy and increased the median survival by 1.6 months and the three-year survival by four […]







